Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin

PURPOSE: Duloxetine and pregabalin are recommended as first-line treatments for diabetic peripheral neuropathic pain (DPNP). However, studies have not reported a direct comparison between duloxetine and pregabalin. We conducted a postmarketing, randomized, double-blind study to assess the noninferio...

Descripción completa

Detalles Bibliográficos
Autores principales: Enomoto, Hiroyuki, Yasuda, Hitoshi, Nishiyori, Atsushi, Fujikoshi, Shinji, Furukawa, Masashi, Ishida, Mitsuhiro, Takahashi, Masashi, Tsuji, Toshinaga, Yoshikawa, Aki, Alev, Levent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145353/
https://www.ncbi.nlm.nih.gov/pubmed/30271191
http://dx.doi.org/10.2147/JPR.S170646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145353/
https://www.ncbi.nlm.nih.gov/pubmed/30271191
http://dx.doi.org/10.2147/JPR.S170646

Ejemplares similares